24 July 2014

Why Opening Up Clinical Trials Data Is Good For Pharma Companies Too

Earlier this year we wrote about how AbbVie, the pharma company spun out of Abbott Laboratories, had gone to court to stop the European Medicines Agency (EMA) from releasing clinical trials information about one of its drugs. Despite what AbbVie claimed, this was not commercially sensitive in any way, but simply basic data about safety and efficacy. 

On Techdirt.

 
{"cc_re__cc_re__cc_publicdomain_zero_1_0": [".getElementById(\"Followers1\"));' target='configFollowers1' title='Edit'>\n<img alt='' height='18' src='https://resources.blogblog.com/img/icon18_wrench_allbkg.png' width='18'/>\n</a>\n</span>\n</span>\n<div class='clear'></div>\n</div>\n</div><div class='widget HTML' data-version='1' id='HTML3'>\n<h2 class='title'>Creative Commons CC0 &#8212; &#8220;No Rights Reserved&#8221;</h2>\n<div class='widget-content'>\n<p xmlns:dct=\"http://purl.org/dc/terms/\" xmlns:vcard=\"http://www.w3.org/2001/vcard-rdf/3.0#\">\n  <a rel=\"license\"\n     href=\"http://creativecommons.org/publicdomain/zero/1.0/\">\n    <img src=\"https://lh5.googleusercontent.com/proxy/N_7FunKnjgIjatTq_nw4VQdXUFBLaNau_UkBGZceh1uq4givcdkxnSopIWK3QawLXWFktzZ6xAmhVW4sRXSMRuongA0O=s0-d\" style=\"border-style: none;\" alt=\"CC0\">\n  </a>\n  <br />\n  To the extent possible under law,\n  <a rel=\"dct:publisher\"\n     href=\"http://opendotdotdot.blogspot.com/\">\n    <span property=\"dct:title\">glyn moody</span></a>\n  has waived all copyright and related or neighbouring rights to\n  this work.\nThis work is published from:\n<span property=\"vcard:"], "copyright__copyright__copyright": ["24 July 2014\n\nWhy Opening Up Clinical Trials Data Is Good For Pharma Companies Too\n\nEarlier this year we wrote about how AbbVie, the pharma company spun out of Abbott Laboratories, had gone to court to stop the European Medicines Agency (EMA) from releasing clinical trials information about one of its drugs. Despite what AbbVie claimed, this was not commercially sensitive in any way, but simply basic data about safety and efficacy.\u00a0\n\nOn Techdirt.\n\n\u00a0", "24 July 2014\n\nWhy Opening Up Clinical Trials Data Is Good For Pharma Companies Too\n\nEarlier this year we wrote about how AbbVie, the pharma company spun out of Abbott Laboratories, had gone to court to stop the European Medicines Agency (EMA) from releasing clinical trials information about one of its drugs. Despite what AbbVie claimed, this was not commercially sensitive in any way, but simply basic data about safety and efficacy.\u00a0\n\nOn Techdirt.\n\n\u00a0", "24 July 2014\n\nWhy Opening Up Clinical Trials Data Is Good For Pharma Companies Too\n\nEarlier this year we wrote about how AbbVie, the pharma company spun out of Abbott Laboratories, had gone to court to stop the European Medicines Agency (EMA) from releasing clinical trials information about one of its drugs. Despite what AbbVie claimed, this was not commercially sensitive in any way, but simply basic data about safety and efficacy.\u00a0\n\nOn Techdirt.\n\n\u00a0", "24 July 2014\n\nWhy Opening Up Clinical Trials Data Is Good For Pharma Companies Too\n\nEarlier this year we wrote about how AbbVie, the pharma company spun out of Abbott Laboratories, had gone to court to stop the European Medicines Agency (EMA) from releasing clinical trials information about one of its drugs. Despite what AbbVie claimed, this was not commercially sensitive in any way, but simply basic data about safety and efficacy.\u00a0\n\nOn Techdirt.\n\n\u00a0", "24 July 2014\n\nWhy Opening Up Clinical Trials Data Is Good For Pharma Companies Too\n\nEarlier this year we wrote about how AbbVie, the pharma company spun out of Abbott Laboratories, had gone to court to stop the European Medicines Agency (EMA) from releasing clinical trials information about one of its drugs. Despite what AbbVie claimed, this was not commercially sensitive in any way, but simply basic data about safety and efficacy.\u00a0\n\nOn Techdirt.\n\n\u00a0", "24 July 2014\n\nWhy Opening Up Clinical Trials Data Is Good For Pharma Companies Too\n\nEarlier this year we wrote about how AbbVie, the pharma company spun out of Abbott Laboratories, had gone to court to stop the European Medicines Agency (EMA) from releasing clinical trials information about one of its drugs. Despite what AbbVie claimed, this was not commercially sensitive in any way, but simply basic data about safety and efficacy.\u00a0\n\nOn Techdirt.\n\n\u00a0"]}